Patents by Inventor Yves Delmotte

Yves Delmotte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6461325
    Abstract: This invention provides a medical device for delivering volumetric quantities of a first and a second biochemically reactive fluid comprising a first container having an opening, the first container being adapted to contain the first biochemically reactive fluid; a second container having a second fluid opening adjacent the first fluid opening, the second container being adapted to contain the second biochemically reactive fluid; a spray unit for separately atomizing the first and second biochemically reactive fluids into an aerosol with at least one energy source of a liquid energy, a mechanical energy, a vibration energy, and an electric energy; a fluid pressurizer for pressurizing the first and the second biochemically reactive fluids for delivery under pressure through the spray unit onto a surface; and wherein the first and second biochemically reactive fluids first mix on the surface.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: October 8, 2002
    Assignee: Baxter International Inc.
    Inventors: Yves Delmotte, Arnold Bilstad, David Amrani, James DiOrio, Atif M. Yardimci, David W. Pennington, James S. Slepicka, Cristina Stadler
  • Publication number: 20020131933
    Abstract: A biopolymermembrane in its substantially dry form having a thickness less than about 75 microns, a solvent content less than about 5% by weight of the membrane, a radius of curvature of less than about 5 centimeters, a density greater than about 1 g/cm3, and a maximum pore size of about 20 microns.
    Type: Application
    Filed: October 26, 2001
    Publication date: September 19, 2002
    Inventor: Yves Delmotte
  • Patent number: 6074663
    Abstract: The self-supporting sheet-like material of cross linked fibrin has a regular pore size. It is used as a bio-mechanical barrier for the treatment of internal traumatic lesions, in particular for the prevention of adhesion formation as a post-operative complication. In the course of this it can be used either alone or in combination with a fibrin glue acting as a haemostatic agent. Since the material in terms of its composition and general structure is similar to endogenous products, it has, inter alia, an excellent bio-compatibility, bio-degradability and bio-resorbability.
    Type: Grant
    Filed: August 28, 1997
    Date of Patent: June 13, 2000
    Assignee: Baxter International Inc.
    Inventors: Yves Delmotte, Genevieve Krack
  • Patent number: 5989215
    Abstract: This invention provides a medical device for delivering volumetric quantities of a first and a second biochemically reactive fluid comprising a first container having an opening, the first container being adapted to contain the first biochemically reactive fluid; a second container having a second fluid opening adjacent the first fluid opening, the second container being adapted to contain the second biochemically reactive fluid; a spray unit for separately atomizing the first and second biochemically reactive fluids into an aerosol with at least one energy source of a liquid energy, a mechanical energy, a vibration energy, and an electric energy; a fluid pressurizer for pressurizing the first and the second biochemically reactive fluids for delivery under pressure through the spray unit onto a surface; and wherein the first and second biochemically reactive fluids first mix on the surface.
    Type: Grant
    Filed: July 12, 1996
    Date of Patent: November 23, 1999
    Assignee: Baxter International Inc.
    Inventors: Yves Delmotte, Arnold Bilstad, David Amrani, Mark Kennedy, James DiOrio
  • Patent number: 5780043
    Abstract: The present invention relates to infection resistant polyurethane having the infection resistant agents incorporated into the matrix of the thermoplastic polyurethane resin. This agent acts as a pool of infection resistant material. This infection resistant material can be used to make gloves and condoms.
    Type: Grant
    Filed: October 18, 1995
    Date of Patent: July 14, 1998
    Inventors: Greg Dane, Jean Kersten, Yves Delmotte
  • Patent number: 5466725
    Abstract: The present invention relates to anti-viral materials. These anti-viral materials have a pool of anti-viral agents acting in cooperation with certain plasticizers to maintain and increase the anti-viral agents efficacy. These anti-viral materials may be used to make surgical gloves, condoms, surgical clothes, surgical operative fields, finger stalls, aprons, bibs and caps.
    Type: Grant
    Filed: December 4, 1991
    Date of Patent: November 14, 1995
    Assignee: Baxter International, Inc.
    Inventors: Jean Kersten, Yves Delmotte
  • Patent number: 5181276
    Abstract: The present invention relates to infection resistant materials and or products made from a molten blend of at least one polymer and a compound having antioxidant, plasticizer and antiviral activity. Additionally, this compound has a hydrophilic lipophilic balance of between 12 and 20. The preferred polymer, polyvinyl chloride, is blended with the antioxidant, plasticizer, antiviral compound NONOXYNOL-9 (.alpha.-nonylphenyl-w-hydroxypoly(oxy-1, 2-ethanediyl) to form the infection resistant material.
    Type: Grant
    Filed: September 9, 1991
    Date of Patent: January 26, 1993
    Assignee: Baxter International Inc.
    Inventors: Jean Kersten, Yves A. Delmotte